Results 111 to 120 of about 320,703 (320)

Association of IL28B Polymorphisms With Hepatitis C Susceptibility in Southern Iran's β‐Thalassemia Population: A Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims Thalassemia is a hereditary hematological condition which interferes with the production of hemoglobin (Hb). Patients with thalassemia require regular blood transfusion, which makes them highly susceptible to pathogens, and especially viral pathogens.
Fatemeh Askari   +5 more
wiley   +1 more source

Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection

open access: yesKaohsiung Journal of Medical Sciences, 2017
Posttransplant hepatitis C virus (HCV) recurrence is universal in chronic hepatitis C recipients. Antiviral therapy is suggested after liver transplant to halt disease progression.
Ta-Ya Lin   +10 more
doaj   +1 more source

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

open access: yesGastroenterology, 2002
BACKGROUND & AIMS Liver fibrosis is an important prognostic factor in patients with hepatitis C. The effect of pegylated (PEG) interferon alone or its combination with ribavirin on fibrosis has not been established.
T. Poynard   +7 more
semanticscholar   +1 more source

Impact of Double Reflex Testing and Linkage to Treatment on Clinical Outcomes of Chronic Hepatitis Delta Virus Infection in the United States

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 1, January 2026.
ABSTRACT Hepatitis D virus (HDV) screening rates in the United States are low. We evaluated the impact of double reflex‐based HDV testing on HDV‐related morbidity and mortality in the United States. A Screen and Treat model simulated the HDV screening cascade (decision tree) and assessed the natural history of HDV (Markov model) over a 5‐year time ...
Robert J. Wong   +8 more
wiley   +1 more source

PEG-INTERFERON ALPHA-2A AND LOW-DOSE RIBAVIRIN FOR TREATMENT OF HEPATITIS C VIRUS INFECTION IN PATIENTS WITH SICKLE CELL ANEMIA IN SAUDI ARABIA.

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2014
Introduction: Data regarding the safety and efficacy of antiviral therapy with pegylated interferon and ribavirin in patients with sickle cell disease and hepatitis C virus (HCV) infection are scanty.
Adnan Agha
doaj  

Clinical significance blood platelet count in patients with chronic hepatitis C on the background of the various options combined antiviral therapy

open access: yesЖурнал инфектологии, 2014
The purpose of this research is the study of the dynamics of platelet count in blood of patients with chronic hepatitis C on the background of the combined antiviral therapy with standard or pegylated interferon-α in combination with ribavirin.
K. V. Zhdanov   +3 more
doaj   +1 more source

Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c. [PDF]

open access: yes, 2018
AimTo determine whether successful treatment with directacting antivirals (DAA) is associated with improvements in hemoglobin A1c (HbA1c) and if type 2 diabetes mellitus (T2DM) or metabolic syndrome affects sustained virologic response (SVR).MethodsWe ...
Aby, Elizabeth S   +6 more
core  

NFB-07. USE OF PEGYLATED INTERFERON α- 2b IN PEDIATRIC PATIENTS AFFECTED BY UNRESECTABLE PLEXIFORM NEUROFIBROMAS: MONOCENTRIC EXPERIENCE [PDF]

open access: hybrid, 2020
Antonella Cacchione   +7 more
openalex   +1 more source

Pharmacokinetic and pharmacodynamic modeling of pegylated-interferon alfa

open access: yesJournal of Hepatology, 2010
Center for the Study of Hepatitis C and Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY, USASee Article, pages 460–467Hepatitis C virus (HCV) infection affects approximately 170 mil-lion individuals worldwide [1,2].
Dimova, Rositsa B., Talal, Andrew H.
openaire   +2 more sources

De novo Cryoglobulinaemic Mononeuritis Multiplex during Treatment of Chronic Hepatitis C Infection: A Viral Effect or Induced by Pegylated Interferon Alpha

open access: yesCase Reports in Gastroenterology, 2012
Cryoglobulinaemic mononeuritis multiplex (MNM) is an extrahepatic manifestation of chronic hepatitis C virus (HCV) infection for which interferon-based antiviral therapy is currently the treatment of choice.
J.R. Potts   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy